Cell
Volume 50, Issue 2, 17 July 1987, Pages 203-213
Journal home page for Cell

Article
Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

https://doi.org/10.1016/0092-8674(87)90216-9Get rights and content

Abstract

The type 2 complement receptor, CR2, a B lymphocyte surface glycoprotein, is known to be a component of the EBV receptor. We now demonstrate that the major EBV outer membrane glycoprotein, gp350/220, is a highly specific ligand for CR2. EBV or beads coated with purified recombinant gp350/220 adsorb to normal B lymphocytes, cap with CR2, become endocytosed into vesicles, and are released into the cytoplasm. This is the first demonstration of herpesvirus glycoprotein-cell glycoprotein receptor interaction in viral adsorption and penetration. The capping of CR2 in response to virus, gp350/220-coated beads, or anti-CR2 monoclonal antibodies is associated with cocapping of surface immunoglobulin. Interaction between CR2 and surface immunoglobulin may be important in modulating the B cell activation that normally follows EBV infection or exposure to antigen.

References (54)

  • M. Biggen et al.

    Transcription and DNA sequence of the BamHI L fragment of Epstein Barr virus

    EMBO J.

    (1984)
  • P.S. Changelian et al.

    Tissue-specific phosphorylation of complement receptors CR1 and CR2

    J. Exp. Med.

    (1986)
  • M. Cleary et al.

    Failure in immunological control of the virus infection: post transplant lymphomas

  • T. Dambaugh et al.

    The virus genome and its expression in latent infection

  • M.H.L. de Bruijn et al.

    Human complement component C3: cDNA coding sequence and derived primary structure

  • C. Edson et al.

    Epstein-Barr virus membrane antigens: characterization distribution and strain differences

    J. Virol.

    (1981)
  • J. Fingeroth et al.

    Epstein-Barr virus receptor on human B lymphocytes is the C3d receptor CR2

  • R. Frade et al.

    Enhancement of human B cell proliferation by an antibody to the C3d receptor, gp 140 molecule

    Eur. J. Immunol.

    (1985)
  • H. Friedman et al.

    Glycoprotein C of herpes simplex type 1 acts as a receptor for C3b complement component on infected cells

    Nature

    (1984)
  • R. Frink et al.

    Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C

    J. Virol.

    (1983)
  • J.W. Goding

    Monoclonal Antibodies Principles and Practice

  • M. Gong et al.

    Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB

    J. Virol.

    (1987)
  • G. Henle et al.

    The virus as the etiologic agent of infectious mononucleosis

  • M. Hummel et al.

    An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins gp350/220

    J. Virol.

    (1984)
  • R. Jack et al.

    Altered surface distribution of both C3b receptors and Fc receptors on neutrophils induced by anti-C3b receptor or aggregated IgG

    J. Immunol.

    (1984)
  • M. Jondal et al.

    Surface markers on human B and T lymphocytes VIII: association between complement and EBV receptors on human lymphoid cells

    Scand. J. Immunol.

    (1976)
  • M.J. Karnovsky

    A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy

    J. Cell Biol.

    (1965)
  • Cited by (0)

    View full text